Table:
0
A
B
C
D
E
1
Name
Platform
Indication
Status
Collaboration
2
TRU-015
SMIP
Rheumatoid arthritis
Phase 2b
Wyeth
3
SBI-087
SMIP
Rheumatoid arthritis
Phase 1
Wyeth
4
SBI-087
SMIP
Systemic lupus erythematosus
Phase 1
Wyeth
5
TRU-016
SMIP
Chronic lymphocytic leukemia
Phase 1/2
Trubion Proprietary Technology
6
TRU-016
SMIP
Non-Hodgkin lymphoma
Pre-clinical
Trubion Proprietary Technology
7
TRU-016
SMIP
Autoimmune disease and inflammation
Pre-clinical
Trubion Proprietary Technology

Questions and formulas:
Question: What company collaborated in SBI-087 for rheumatoid arthritis?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:E1,(A1="sbi-087")*(C1="rheumatoid arthritis")),5))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:E7,(A2:A7="sbi-087")*(C2:C7="rheumatoid arthritis")),5))
Level: medium
Question: What company collaborated in non-hodgkin lymphoma?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:E1,C1="non-hodgkin lymphoma"),5))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:E7,C2:C7="non-hodgkin lymphoma"),5))
Level: medium
Question: What company collaborated in pre-clinical autoimmune disease and inflammation?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:E1,(D1="pre-clinical")*(C1="autoimmune disease and inflammation")),5))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:E7,(D2:D7="pre-clinical")*(C2:C7="autoimmune disease and inflammation")),5))
Level: medium
Question: Which study included autoimmune disease and inflammation?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:E1,C1="autoimmune disease and inflammation"),1))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:E7,C2:C7="autoimmune disease and inflammation"),1))
Level: medium
Question: What did the phase 2b status target?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:E1,D1="phase 2b"),3))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:E7,D2:D7="phase 2b"),3))
Level: medium
Question: What company collaborated with non-hodgkin lymphoma?
Formula: UNIQUE(CHOOSECOLS(FILTER(A1:E1,C1="non-hodgkin lymphoma"),5))
Formula2: UNIQUE(CHOOSECOLS(FILTER(A2:E7,C2:C7="non-hodgkin lymphoma"),5))
Level: medium